Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases

被引:375
作者
d'Ortho, MP
Will, H
Atkinson, S
Butler, G
Messent, A
Gavrilovic, J
Smith, B
Timpl, R
Zardi, L
Murphy, G
机构
[1] Fac Med, INSERM U296, F-94010 Creteil, France
[2] Strangeways Res Lab, Cambridge CB1 4RN, England
[3] InVitek GMBH, Berlin, Germany
[4] Celltech Therapeut Ltd, Slough, Berks, England
[5] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[6] Ist Nazl Ric Canc, Cell Biol Lab, I-16132 Genoa, Italy
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1997年 / 250卷 / 03期
关键词
tissue inhibitor of matrix metalloproteinase; extracellular matrix; cytokine; wound healing; invasion;
D O I
10.1111/j.1432-1033.1997.00751.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Soluble proenzyme forms of the catalytic domains of membrane-type matrix metalloproteinases 1 and 2 (MT1-MMP and MT2-MMP) and a form of MT1-MMP containing the catalytic and hemopexin domains were expressed as soluble recombinant proteins. Purified, activated forms of the MT-MMP were shown to degrade fibronectin, tenascin, nidogen, aggrecan and perlecan. Only MT2-MMP showed activity against laminin. MT1-MMP retaining the hemopexin domain was able to specifically cleave native type-I and type-III collagens into the 3/4-1/4 fragments typical of the specific collagenases. The catalytic domain alone did not retain this activity. The MT-MMP did not degrade interleukin-1 beta, but, similarly to many other MMP, could process a pro [tumor necrosis factor (TNF) alpha] fusion protein to release mature TNF. However, the latter was subsequently degraded into smaller fragments. These results demonstrate that, in addition to their ability to activate other MMP, such as progelatinase A/proMMP2 and procollagenase-3/proMMP13, MT-MMP degrade a number of extracellular matrix macromolecules. Their location at the surface of cells implies that they could play a significant role in the modulation of cell-matrix interactions.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 42 条
  • [1] THE GENE STRUCTURE OF TISSUE INHIBITOR OF METALLOPROTEINASES (TIMP)-3 AND ITS INHIBITORY ACTIVITIES DEFINE THE DISTINCT TIMP GENE FAMILY
    APTE, SS
    OLSEN, BR
    MURPHY, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) : 14313 - 14318
  • [2] ASTACINS, SERRALYSINS, SNAKE-VENOM AND MATRIX METALLOPROTEINASES EXHIBIT IDENTICAL ZINC-BINDING ENVIRONMENTS (HEXXHXXGXXH AND MET-TURN) AND TOPOLOGIES AND SHOULD BE GROUPED INTO A COMMON FAMILY, THE METZINCINS
    BODE, W
    GOMISRUTH, FX
    STOCKLER, W
    [J]. FEBS LETTERS, 1993, 331 (1-2) : 134 - 140
  • [3] Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases
    Butler, GS
    Will, H
    Atkinson, SJ
    Murphy, G
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 244 (02): : 653 - 657
  • [4] RAPID AND REPRODUCIBLE ASSAY FOR COLLAGENASE USING [ACETYLATED-1-C-14 COLLAGEN
    CAWSTON, TE
    BARRETT, AJ
    [J]. ANALYTICAL BIOCHEMISTRY, 1979, 99 (02) : 340 - 345
  • [5] FIBRONECTIN MATRIX DEPOSITION AND FIBRONECTIN RECEPTOR EXPRESSION IN HEALING AND NORMAL SKIN
    CLARK, RAF
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (06) : S128 - S134
  • [6] Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan
    Costell, M
    Sasaki, T
    Mann, K
    Yamada, Y
    Timpl, R
    [J]. FEBS LETTERS, 1996, 396 (2-3) : 127 - 131
  • [7] Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides
    Costell, M
    Mann, K
    Yamada, Y
    Timpl, R
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2): : 115 - 121
  • [8] Deryugina EI, 1996, J CELL SCI, V109, P643
  • [9] RECOMBINANT NIDOGEN CONSISTS OF 3 GLOBULAR DOMAINS AND MEDIATES BINDING OF LAMININ TO COLLAGEN TYPE-IV
    FOX, JW
    MAYER, U
    NISCHT, R
    AUMAILLEY, M
    REINHARDT, D
    WIEDEMANN, H
    MANN, K
    TIMPL, R
    KRIEG, T
    ENGEL, J
    CHU, ML
    [J]. EMBO JOURNAL, 1991, 10 (11) : 3137 - 3146
  • [10] RELEASE OF BIOLOGICAL-ACTIVITIES FROM QUIESCENT FIBRONECTIN BY A CONFORMATIONAL CHANGE AND LIMITED PROTEOLYSIS BY MATRIX METALLOPROTEINASES
    FUKAI, F
    OHTAKI, M
    FUJII, N
    YAJIMA, H
    ISHII, T
    NISHIZAWA, Y
    MIYAZAKI, K
    KATAYAMA, T
    [J]. BIOCHEMISTRY, 1995, 34 (36) : 11453 - 11459